Oxford, United Kingdom

James Spencer

This inventor holds 1 USPTO granted patent. Top assignee: Oxford University Innovation Ltd. Active years: 2024.

IDiyas Innovation Intelligence. (2026). Inventor Profile: James Spencer. Retrieved from https://idiyas.com/inventor/james-spencer-q8gymkos

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 9.0

ph-index = 1


Company Filing History:


Years Active: 2024

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of James Spencer

Introduction

James Spencer is an accomplished inventor based in Oxford, GB. He has made significant contributions to the field of medicine, particularly in the development of treatments for tuberculosis and infections. His work focuses on the use of β-lactamase inhibitors in conjunction with β-lactam antibiotics.

Latest Patents

James Spencer holds 1 patent related to his innovative work. His patent specifically addresses the use of certain β-lactamase inhibitors for the treatment of tuberculosis and infections. This invention is crucial in enhancing the effectiveness of antibiotic treatments.

Career Highlights

James Spencer is associated with Oxford University Innovation Ltd, where he continues to advance his research and development efforts. His expertise in the field has positioned him as a key figure in the fight against antibiotic resistance.

Collaborations

James has collaborated with notable colleagues, including Jürgen Brem and Matthew B Avison. These partnerships have further enriched his research and contributed to the success of his inventions.

Conclusion

James Spencer's innovative work in the field of medicine, particularly with β-lactamase inhibitors, showcases his dedication to improving treatment options for serious infections. His contributions are vital in the ongoing battle against antibiotic resistance.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…